Table of Content

1. Product Overview
2. Research Methodology
3. Impact of COVID-19 on United Kingdom Veterinary Medicine Market
4. Executive Summary
5. Voice of Customers
6. United Kingdom Veterinary Medicine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Animal Type (Production v/s Companion)
6.2.1.1. By Production (Poultry, Swine, Cattle, Others)
6.2.1.2. By Companion (Dogs, Cats, Horses, Others)
6.2.2. By Product Type (Vaccine, Pharmaceuticals, Medicated Feed Additives)
6.2.3. By End User (Veterinary Hospitals & Clinics, Reference Laboratories, Others)
6.2.4. By Source (Domestic v/s Import)
6.2.5. By Region
6.2.6. By Company (2021)
6.3. Product Market Map
7. United Kingdom Veterinary Vaccine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type (Inactive Vaccines, Attenuated Vaccines, Recombinant Vaccines, Others)
7.2.2. By End User
7.2.3. By Source
8. United Kingdom Veterinary Pharmaceuticals Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type (Parasiticides, Analgesics, Anti-Inflammatory, Anti-infectives, Others)
8.2.2. By End User
8.2.3. By Source
9. United Kingdom Veterinary Medicated Feed Additives Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type (Aminoacids, Antibiotics, Others)
9.2.2. By End User
9.2.3. By Source
10. Market Dynamics
10.1. Drivers
10.2. Challenges
11. Market Trends & Developments
12. Policy & Regulatory Landscape
13. Import-Export Analysis
14. United Kingdom Economic Profile
15. Competitive Landscape
15.1. Dechra Pharmaceuticals PLC
15.2. Norbrook Laboratories Ltd
15.3. Elanco Animal Health UK Limited
15.4. Bayer Plc.
15.5. Boehringer Ingelheim Animal Health UK Limited
15.6. Ceva Animal Health Limited
15.7. Covetrus Animal Health Holdings Limited
15.8. KRKA UK Ltd
15.9. TVM UK
15.10. Vetoquinol UK Limited
16. Strategic Recommendations